Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer.
Rashid NS, Boyd DC, Olex AL, Grible JM, Duong AK, Alzubi MA, Altman JE, Leftwich TJ, Valentine AD, Hairr NS, Zboril EK, Smith TM Jr, Pfefferle AD, Dozmorov MG, Harrell JC.
Rashid NS, et al.
Sci Rep. 2022 Dec 8;12(1):21248. doi: 10.1038/s41598-022-25541-3.
Sci Rep. 2022.
PMID: 36482068
Free PMC article.
Comparison of all three data types revealed five genes that were upregulated across all erlotinib-resistant samples: IL19, KLK7, LCN2, SAA1, and SAA2. Of these five genes, LCN2 was most abundantly expressed in triple-negative breast cancers, and its knockdown restor …
Comparison of all three data types revealed five genes that were upregulated across all erlotinib-resistant samples: IL19, KLK7, LCN2 …